Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI) to Provide Human Connection Through Communication

NCT07357428 is registered in ClinicalTrials.gov with Paradromics as lead sponsor.

NCT NCT07357428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07357428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI) to Provide Human Connection Through Communication
Lead sponsor
Paradromics
Phase
Not applicable
Overall status
Recruiting
Start date
March 31, 2026
Completion date
January 31, 2032
Enrollment
2 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

amyotrophic lateral sclerosis, cervical spinal cord injury, dysarthria, neuromuscular disease, stroke, tetraplegia/tetraparesis